Cargando…

P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140

Detalles Bibliográficos
Autores principales:	Donnelly, L, Curran, RM, Morrow, RJ, Kett, VL, Andrews, GP, Malcolm, RK, Woolfson, AD, Shattock, RJ
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767644/ http://dx.doi.org/10.1186/1742-4690-6-S3-P156

Ejemplares similares

P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140
por: Morrow, RJ, et al.
Publicado: (2009)

Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms
por: Donnelly, Louise, et al.
Publicado: (2011)

Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses
por: Curran, Rhonda M., et al.
Publicado: (2009)

Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation
por: Mann, JF, et al.
Publicado: (2012)

Antibody responses after intravaginal immunisation with trimeric HIV-1(CN54) clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation
por: Cranage, Martin P., et al.
Publicado: (2011)

Phase I Randomised Clinical Trial of an HIV-1(CN54), Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally
por: Lewis, David J., et al.
Publicado: (2011)

Antigen-specific T lymphocyte responses elicited by a DNA – MVA HIV CN54gp140 immunization regime are significantly altered by the TLR4 adjuvant GLA
por: McKay, PF, et al.
Publicado: (2012)

Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations
por: Pattani, Aditya, et al.
Publicado: (2012)

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization
por: Katinger, D, et al.
Publicado: (2012)

Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen()
por: Mann, J.F.S., et al.
Publicado: (2012)

Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, PF, et al.
Publicado: (2012)

Hydrogel-Forming Microneedles Prepared from “Super Swelling” Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery
por: Donnelly, Ryan F., et al.
Publicado: (2014)

P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses
por: Mann, JF, et al.
Publicado: (2009)

Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate
por: Visciano, Maria Luisa, et al.
Publicado: (2013)

P19-54 LB. Interrogating the membrane-proximal external region (MPER) of HIV-1 gp140
por: Jeffs, S, et al.
Publicado: (2009)

Ecogenomics of the SAR11 clade
por: Haro‐Moreno, Jose M., et al.
Publicado: (2019)

Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial
por: Gombe, Ben, et al.
Publicado: (2022)

Yeasts preservation: alternatives for lyophilisation
por: Nyanga, Loveness K., et al.
Publicado: (2012)

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens
por: Kratochvil, Sven, et al.
Publicado: (2017)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
por: Spearman, P, et al.
Publicado: (2012)

Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers
por: Msafiri, Frank, et al.
Publicado: (2020)

Collagen-Fibrinogen Lyophilised Scaffolds for Soft Tissue Regeneration
por: Shepherd, Jennifer, et al.
Publicado: (2017)

Lyophilised Platelet-Rich Fibrin: Physical and Biological Characterisation
por: Ngah, Nurul Aida, et al.
Publicado: (2021)

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial
por: Joachim, Agricola, et al.
Publicado: (2016)

Optimising the collection of female genital tract fluid for cytokine analysis in pregnant women
por: Short, C.S., et al.
Publicado: (2018)

Optimization of production, purification and lyophilisation of cellobiose dehydrogenase by Sclerotium rolfsii
por: Fischer, Christin, et al.
Publicado: (2014)

Phylogenomic evidence for a common ancestor of mitochondria and the SAR11 clade
por: Thrash, J. Cameron, et al.
Publicado: (2011)

Antigenicity of soluble HIV gp140 trimers reveals differences in solution conformation for differing HIV strains
por: Gearhart, TL, et al.
Publicado: (2012)

Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
por: Kong, Leopold, et al.
Publicado: (2016)

Monomers, dimers, and trimers of [Au(CN)(2)](−) in a Ba(diaza-18-crown-6)(2+) coordination polymer
por: Beavers, Christine M., et al.
Publicado: (2009)

Glycosylation and Disulfide Bond Analysis of Transiently and Stably Expressed Clade C HIV-1 gp140 Trimers in 293T Cells Identifies Disulfide Heterogeneity Present in Both Proteins and Differences in O-Linked Glycosylation
por: Go, Eden P., et al.
Publicado: (2014)

Recent Advances and Future Direction in Lyophilisation and Desiccation of Mesenchymal Stem Cells
por: Bissoyi, Akalabya, et al.
Publicado: (2016)

Characterization and evaluation of avermectin solid nanodispersion prepared by microprecipitation and lyophilisation techniques
por: Cui, Bo, et al.
Publicado: (2018)

P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein
por: Cranage, M, et al.
Publicado: (2009)

Inverse dose-response to gp140 YU2 foldon trimer formulated with aluminum phosphate and ISCOMATRIX® adjuvants
por: Wilson, A, et al.
Publicado: (2012)

140 Scoping Review of the Health Effects of Youth Due to the September 11, 2001 Terrorist Attacks
por: Santiago-Colãn, Albeliz, et al.
Publicado: (2023)

Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein
por: van Haaren, M. M., et al.
Publicado: (2021)

Naked Plasmid DNA Formulation: Effect of Different Disaccharides on Stability after Lyophilisation
por: Quaak, Susanne G. L., et al.
Publicado: (2010)

Measurement of Subvisible Particulates in Lyophilised Erwinia chrysanthemil-asparaginase and Relationship with Clinical Experience
por: Gervais, David, et al.
Publicado: (2014)

Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles
por: Amelian, Aleksandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2abtndiddjqul1vcciqqnetra8